• 검색 결과가 없습니다.

Impacts of disease activity and neurotrophic factors on depression in rheumatoid arthritis

N/A
N/A
Protected

Academic year: 2022

Share "Impacts of disease activity and neurotrophic factors on depression in rheumatoid arthritis"

Copied!
1
0
0

로드 중.... (전체 텍스트 보기)

전체 글

(1)

392

S-685

Generation of new carotid plaque is influenced by ongoing disease activity of rheumatoid arthritis

Division of Rheumatology, Department of Internal Medicine, Kyungpook National University School of Medicine, Daegu, Republic of Korea

*Jong Wan Kang, Eun Song Lee, Jung Su Eun, Na Ri Kim, Ji Hun Kim, Jin Young Kang, Eon Jeong Nam, Young Mo Kang

Background/Purpose: Rheumatoid arthritis (RA) is associated with an increased susceptibility to cardiovascular (CV) disease which has a causal re- lationship with carotid atherosclerosis. In the present study, we investigated the risk factors for progression of carotid atherosclerosis in RA patients in the Kyungpook National University Hospital Atherosclerosis Risk in Rheumatoid Arthritis (KARRA) cohort study. Methods: After a baseline evalua- tion for KARRA enrollment, all RA patients and healthy controls were prospectively followed up for 5 years or until deaths. We analyzed the demo- graphic findings, conventional risk factors and RA disease activity. Carotid ultrasound at baseline and year 5 was performed to evaluation of the in- tima-medial thickness (IMT) and presence and progression of carotid plaque. Results: A total of 417 RA patients and 221 age- and sex- matched healthy controls were included at baseline, and 325 RA patients and 160 healthy controls were followed for the 5 year period. Mean age and female fre- quency of RA patients were not different compared with those of healthy controls. At year 5, the mean carotid IMT of RA patients was higher than that of controls [0.85 mm (S.D. 0.15) vs. 0.88 (S.D. 0.18), p=0.04]. New development of carotid plaques at year 5 in RA patients (n=93) was predicted by IMT and total and LDL cholesterols at baseline, while it was associated with IMT and DAS28-CRP at year 5. Multivariate logistic regression analysis revealed that baseline IMT (OR 72.14 [95% CI 5.15-101.12; p=0.001]) and DAS28-CRP at year 5 (OR 1.69 [95% CI 1.15-2.48; p=0.008]) were in- dependent risk factors for new plaque formation in 5 year followed period. Conclusions: This study shows that generation of new carotid plaque after long-term follow-up depends on the preexisting carotid atherosclerosis that is aggravated by suboptimal disease control.

S-686

Impacts of disease activity and neurotrophic factors on depression in rheumatoid arthritis

1Department of Internal Medicine and Institute of Health Science, Gyeongsang National University School of Medicine, Jinju, 2Department of Internal Medicine, Gyeongsang National University Changwon Hospital, Changwon, Republic of Korea

*Hyun Gyung Jang1, MinYoung Kim1, Young Sun Suh2, Hyun-Ok Kim2, Sang-Il Lee1, Yun-Hong Cheon1

Background: Rheumatoid arthritis (RA) and depression is closely associated with each other. The neurotrophic factors are related with major depres- sive disorder (MDD). However, the impacts of disease activity, pro-inflammatory cytokines and neurotrophic factors on depression in RA patients have not well studied. Objectives: To determine the risk factors for depression and to examine the effect of disease activity, pro-inflammatory cytokines and neurotrophic factors on depression in patients with RA. Methods: This cross sectional study was conducted from Jan, 2014 to Jan, 2015 from 3 uni- versity hospitals. Demographic and laboratory data were examined and routine assessment of patient index data 3 (RAPID 3) questionnaire and 28 joints disease activity score (DAS28-CRP) were assessed for disease activity. Depression was measured by Korean version of the Beck Depression Inventory second edition (K-BDI II). Serum level of pro-inflammatory cytokines and neurotrophic factors such as BDNF, VEGF, GDNF, and IGF-1 were assessed by ELISA. Results: A total of 507 RA patients were recruited. The prevalence of depression was 33.1% (n=168). RAPID 3 score (OR 1.2, 95% CI 1.1-1.4, p=0.006) and severity of fatigue (OR 1.19, 95%CI 1.07-1.32, p=0.001) showed significant associations with depression in multi- variate analysis. The RA patients with DAS 28-CRP ≥3.2 (n=126) had more risk for depression than those with DAS 28-CRp<3.2 (n=279) in multi- variate analysis (OR 2.02 95% CI 1.34-3.06, p=0.006). When patients was followed up for a year after strict treatment, as DAS28-CRP decreased, BDI score also decreased (ΔDAS28-CRP: -1.4±1.6, and ΔK-BDI II: -5.4±10.1, p<0.001). There were no relationships between pro-inflammatory cytokines and depression (IL-1β: r=0.057, IL-6: r=0.169, TNF-α: r=-0.078). In the case of neurotrophic factors, the level of BDNF showed weakly correlation with K-BDI II score (r=-0.233, p<0.001). Conclusions: This study suggests strict control of fatigue and disease activity is important in regulating de- pressive symptoms in patients with RA. To evaluate psychologic manifestation of RA patients, using both RAPID 3 score and DAS28 might be helpful.

참조

관련 문서

Current Tokyo is rich in green compared to other metro cities. In some parts, the greenery has been contributed by the many inherited gardens from the Edo era to today which

influence of tobacco smoking and other risk factors on the risk of kidney cancer in a Japanese population, using data from the Japan Collaborative Cohort Study for

(2000) 32) ADHD, attention deficit hyperactivity disorder; VR, virtual reality; CPT, continuous performance test; VC, virtual classroom; TOVA, Test of Variables of Attention;

[r]

노인 만성폐쇄성폐질환 환자들은 인플루엔자에 대한 합 병증의 위험이 높아서 매년 인플루엔자 예방접종을 받아야 한다. 폐렴구균 예방접종은 논란이 되기는 하지만 평생 1회

혼합제를 사용하여도 천식 조 절이 되지 않는 경우 경구 약제인 류코트리엔 조절제 그리 고 (또는) 테오필린을 추가하여 사용한다. 류코트리엔은 효 과 면에서는

The prevalence and correlates of fear of falling in elderly persons living in the community. Prevalence and associated factors of falls in the elderly community. A Study on

12) Maestu I, Gómez-Aldaraví L, Torregrosa MD, Camps C, Llorca C, Bosch C, Gómez J, Giner V, Oltra A, Albert A. Gemcitabine and low dose carboplatin in the treatment of